Literature DB >> 30371795

Glucose-Mediated Glucose Disposal at Baseline Insulin Is Impaired in IFG.

Mariam Alatrach1, Christina Agyin1, Rucha Mehta1, John Adams1, Ralph A DeFronzo1, Muhammad Abdul-Ghani1.   

Abstract

Objective: To quantify glucose-mediated glucose disposal with and without basal insulin replacement and insulin-mediated glucose disposal in subjects with impaired fasting glucose (IFG). Research Design and
Methods: We used the hyperglycemic/pancreatic clamp and stepped euglycemic clamp techniques to quantify glucose disposal and suppression of endogenous glucose production (EGP) in those with normal glucose tolerance (NGT; n = 14) and those with IFG (n = 14).
Results: Total body glucose-mediated glucose uptake, measured with the hyperglycemic/pancreatic clamp, was not significantly affected by the basal plasma insulin levels in subjects with IFG and those with NGT. Compared with subjects with NGT, those with IFG had significantly lower glucose-mediated glucose uptake (by 15%) during the hyperglycemic clamp performed with and without basal insulin replacement. In contrast, insulin-mediated glucose disposal was comparable in both groups. The suppression of EGP by hyperglycemia was similar in both groups. However, the suppression of EGP by insulin was attenuated in those with IFG compared with those with NGT. Conclusions: The results of the present study have demonstrated that (i) glucose-mediated glucose disposal is impaired in those with IFG; (ii) insulin-mediated glucose uptake in IFG is normal; and (iii) insulin action to suppress EGP is impaired.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30371795      PMCID: PMC6286408          DOI: 10.1210/jc.2017-01866

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  36 in total

1.  Who are more insulin resistant, people with IFG or people with IGT?

Authors:  T Wasada; H Kuroki; K Katsumori; H Arii; A Sato; K Aoki
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

2.  Impaired fasting glucose with or without impaired glucose tolerance: progressive or parallel states of prediabetes?

Authors:  Leigh Perreault; Bryan C Bergman; Mary C Playdon; Chiara Dalla Man; Claudio Cobelli; Robert H Eckel
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-06-03       Impact factor: 4.310

3.  Strong association between insulin-mediated glucose uptake and the 2-hour, not the fasting plasma glucose concentration, in the normal glucose tolerance range.

Authors:  Diedre Winner; Luke Norton; Mustafa Kanat; Ruth Arya; Marcel Fourcaudot; Andrea Hansis-Diarte; Devjit Tripathy; Ralph A DeFronzo; Christopher P Jenkinson; Muhammad Abdul-Ghani
Journal:  J Clin Endocrinol Metab       Date:  2014-05-05       Impact factor: 5.958

Review 4.  Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

Authors:  R A DeFronzo
Journal:  Diabetes       Date:  1988-06       Impact factor: 9.461

5.  Decreased basal hepatic glucose uptake in impaired fasting glucose.

Authors:  Mariam Alatrach; Christina Agyin; John Adams; Ralph A DeFronzo; Muhammad A Abdul-Ghani
Journal:  Diabetologia       Date:  2017-03-22       Impact factor: 10.122

6.  Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.

Authors:  C Miele; P Formisano; G Condorelli; M Caruso; F Oriente; F Andreozzi; C G Tocchetti; G Riccardi; F Beguinot
Journal:  Diabetologia       Date:  1997-04       Impact factor: 10.122

Review 7.  Pathogenesis of insulin resistance in skeletal muscle.

Authors:  Muhammad A Abdul-Ghani; Ralph A DeFronzo
Journal:  J Biomed Biotechnol       Date:  2010-04-26

8.  Glucose transporters and in vivo glucose uptake in skeletal and cardiac muscle: fasting, insulin stimulation and immunoisolation studies of GLUT1 and GLUT4.

Authors:  E W Kraegen; J A Sowden; M B Halstead; P W Clark; K J Rodnick; D J Chisholm; D E James
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

9.  Decreased non-insulin-dependent glucose clearance contributes to the rise in fasting plasma glucose in the nondiabetic range.

Authors:  Rucha Jani; Marjorie Molina; Masafumi Matsuda; Bogdan Balas; Alberto Chavez; Ralph A DeFronzo; Muhammad Abdul-Ghani
Journal:  Diabetes Care       Date:  2007-11-13       Impact factor: 19.112

10.  Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM.

Authors:  C Y Jeng; W H Sheu; M M Fuh; Y D Chen; G M Reaven
Journal:  Diabetes       Date:  1994-12       Impact factor: 9.461

View more
  2 in total

1.  Obesity Is Associated With Increased Basal and Postprandial β-Cell Insulin Secretion Even in the Absence of Insulin Resistance.

Authors:  Stephan van Vliet; Han-Chow E Koh; Bruce W Patterson; Mihoko Yoshino; Richard LaForest; Robert J Gropler; Samuel Klein; Bettina Mittendorfer
Journal:  Diabetes       Date:  2020-07-10       Impact factor: 9.461

2.  Effect of obstructive sleep apnea on glucose metabolism.

Authors:  Han-Chow E Koh; Stephan van Vliet; Chao Cao; Bruce W Patterson; Dominic N Reeds; Richard Laforest; Robert J Gropler; Yo-El S Ju; Bettina Mittendorfer
Journal:  Eur J Endocrinol       Date:  2022-02-23       Impact factor: 6.558

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.